Externally applied agent for treating hyperosteogeny, disc herniation, cervical vertebra inflammation and rheumathritis

Abstract

The invention discloses an external applying agent for curing hyperosteogeny, disc herniation, cervical spine inflammation and rheumatoid arthritis, belonging to the geat saamc xiaoy. The invention aims to provide an external applying agent for curing the symptoms such as hyperosteogeny and rheumatoid arthritis. The external applying agent is made by angled bittersweet root, achyranthes, angelica, loosestrife, radix aconiti feri, garden balsam stem and Vitis davidii. The compositions by weight portion are: 30 to 40 portions of angled bittersweet root, 30 to 40 portions of achyranthes, 25 to 30 portions of angelica, 20 to 25 portions of loosestrife, 10 to 15 portions of radix aconiti feri, 15 to 20 portions of garden balsam stem and 30 to 40 portions of Vitis davidii. The method for makingthe external applying agent is as follows: the raw material medicines are washed off, aired or sun-dried, grinded into powder, and are mixed evenly and then stirred by 100 portions of alcohol with 52 to 56 degrees and are mixed into paste with 40 portions of ripe teal oil. The external applying agent has the advantages of short period of treatment, rapid odynolysis, good healing effect and convenient use, etc., thereby being an ideal medicine for curing symptoms such as hyperosteogeny.

Description

Technical field: [0001] The invention relates to a Chinese herbal medicine, in particular to an externally applied seedling medicine for treating hyperosteogeny, intervertebral disc herniation, cervical spondylitis, frozen shoulder and rheumatoid arthritis. Background technique: [0002] Osteoarthritis, intervertebral disc herniation, cervical spondylitis, and rheumatoid arthritis are common and frequently-occurring diseases of middle-aged and elderly people. Due to local pain, swelling, and numbness, patients experience various dysfunctions, which affect life and work in mild cases, and in severe cases. Then quadriplegia, loss of working ability. [0003] At present, there are many types of drugs clinically used for the treatment of hyperosteogeny, herniated intervertebral disc, cervical spondylitis, frozen shoulder, and rheumatoid arthritis. Only the effect of inhibition and analgesia cannot fundamentally eliminate the lesion. The shortcomings of medicines such as anti-b...

AI Technical Summary

Problems solved by technology

[0003] At present, there are many types of drugs clinically used for the treatment of hyperosteogeny, herniated intervertebral disc, cervical spondylitis, frozen shoulder, and rheumatoid arthritis. Only inhibit and analgesic effect, can not fundamentally eliminate the lesion

The shortcomings of medicines such as anti-bone hyperplasia pills, Jingfukang capsules, and Jingtongning granules sold on the market are that the medicines are absorbed by the whole body and are difficult to reach the affected area, requiring a larger dose; Although liquid and other liquors can reach the affected area, their use will be limited for patients who are not good at drinking alcohol; and decoctions must be taken for a long time, which is troublesome; traditional plasters such as Guciting and Fengshizhitong ointment in external medicine have poor air permeability. It is easy to cause symptoms such as skin allergies; external liniments such as Guzhining are easy to volatilize, and the curative effect is not significant